Zhejiang CONBA Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 3,764.54 million compared to CNY 3,080.89 million a year ago. Net income was CNY 516.13 million compared to CNY 212.39 million a year ago.

Basic earnings per share from continuing operations was CNY 0.201 compared to CNY 0.083 a year ago.